VolitionRX Ltd (NYSE American:VNRX)
| 2.32 Delayed Data As of 3:59pm ET |  +0.20 / +9.43%Today’s Change | 1.95 Today|||52-Week Range 4.14 | -26.11% Year-to-Date |
Latest VNRX News | Press Releases
No recent news for VolitionRX Ltd.
Today’s Trading
| Previous close | 2.12 |
| Today’s open | 2.20 |
| Day’s range | 2.20 - 2.32 |
| Volume | 74,511 |
| Average volume (3 months) | 67,380 |
| Market cap | $108.8M |
Data as of 3:59pm ET, 07/06/2022
Growth & Valuation
| Earnings growth (last year) | -13.28% |
| Earnings growth (this year) | -5.88% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +570.25% |
| P/E ratio | NM |
| Price/Sales | 1,836.39 |
| Price/Book | 6.05 |
Competitors
| ---- |
| ---- |
| ---- |
| ---- |
Data as of 12/30/1899
Financials
| Next reporting date | August 15, 2022 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $90.0K |
| Annual profit (last year) | -$26.8M |
| Net profit margin | -29,782.49% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Austin, Texas |
Forecasts
